InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by CARMINE STENGONE. Insider active across 1 company, notably Contineum Therapeutics, Inc.. Aggregated, 1 reports have been recorded. Activity tracked since 8 July 2026. The latest transaction was filed on 8 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration